Abstract
A case of myocardial infarction secondary to dipyridamole overdose is described in a 62-year-old woman with longstanding angina. Therapeutic doses of dipyridamole are associated with reversible myocardial ischaemia in a proportion of patients but serious adverse events are rare (Homma et al., 1987). To our knowledge this is the first reported case of dipyridamole overdose in the literature.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bayliss J., Pearson M., Sutton G. C. Ventricular dysrhythmias following intravenous dipyridamole during "stress" myocardial imaging. Br J Radiol. 1983 Sep;56(669):686–686. doi: 10.1259/0007-1285-56-669-686. [DOI] [PubMed] [Google Scholar]
- Biddle P., Lanspa T. J., Mohiuddin S. M., Malesker M. A., Hilleman D. E. Myocardial infarction after dipyridamole-assisted thallium-201 imaging. DICP. 1989 Sep;23(9):665–667. doi: 10.1177/106002808902300907. [DOI] [PubMed] [Google Scholar]
- Blumenthal M. S., McCauley C. S. Cardiac arrest during dipyridamole imaging. Chest. 1988 May;93(5):1103–1104. doi: 10.1378/chest.93.5.1103. [DOI] [PubMed] [Google Scholar]
- Homma S., Gilliland Y., Guiney T. E., Strauss H. W., Boucher C. A. Safety of intravenous dipyridamole for stress testing with thallium imaging. Am J Cardiol. 1987 Jan 1;59(1):152–154. doi: 10.1016/s0002-9149(87)80089-9. [DOI] [PubMed] [Google Scholar]
- KADATZ R. Die pharmakologischen Eigenschaften der neuen coronarerweiternden Substanz 2,6-Bis(diaethanolamino)-4, 8-dipiperidino-pyrimido(5,4-d)pyrimidin. Arzneimittelforschung. 1959 Jan;9(1):39–45. [PubMed] [Google Scholar]
- Keltz T. N., Innerfield M., Gitler B., Cooper J. A. Dipyridamole-induced myocardial ischemia. JAMA. 1987 Mar 20;257(11):1515–1516. doi: 10.1001/jama.257.11.1515. [DOI] [PubMed] [Google Scholar]
- Lette J., Cerino M., Laverdiere M., Tremblay J., Prenovault J. Severe bronchospasm followed by respiratory arrest during thallium-dipyridamole imaging. Chest. 1989 Jun;95(6):1345–1347. doi: 10.1378/chest.95.6.1345. [DOI] [PubMed] [Google Scholar]
- Miura M., Tominaga S., Hashimoto K. Potentiation of reactive hyperemia in the coronary and femoral circulation by the selective use of 2,6-bis(diethanolamino)-4,8-dipiperidino-pyrimodo[5,4-d]pyrimidine. Arzneimittelforschung. 1967 Aug;17(8):976–979. [PubMed] [Google Scholar]
- Moncada S., Vane J. R. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev. 1978 Sep;30(3):293–331. [PubMed] [Google Scholar]
- Rivey M. P., Alexander M. R., Taylor J. W. Dipyridamole: a critical evaluation. Drug Intell Clin Pharm. 1984 Nov;18(11):869–880. doi: 10.1177/106002808401801103. [DOI] [PubMed] [Google Scholar]
- Virtanen K. S., Mattila S., Järvinen A., Frick M. H. Angiographic findings in patients exhibiting ischemia after oral dipyridamole. Int J Cardiol. 1989 Apr;23(1):33–36. doi: 10.1016/0167-5273(89)90326-4. [DOI] [PubMed] [Google Scholar]